Minireview: update on incretin biology: focus on glucagon-like peptide-1
Options such as protein powders, ready-to-drink shakes, meal replacements, and electrolyte supplements make it easier for patients to meet their daily nutritional requirements without relying on large meals
A poll released Friday by KFF found that about 1 in 8 adults say they are currently taking a GLP-1 drug to treat a chronic disease, for weight loss or both an increase of 6% since May 2024
The conversation highlights the strong bidirectional relationship between insulin resistance and thyroid dysfunction, including how each can worsen the other when left unaddressed
The hope is that this dual approach might lead to: Enhanced Weight Loss: Beyond Retatrutide's already impressive results, MOTS-c might further optimize fat burning and metabolic adaptation
The Challenge: Why Not Just Use Medications to Increase GLP-1